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universities, 45% were tertiary care centres, and 8% were sec-
ondary care hospitals. A total of 60 RS (Germany 35, Austria 8, 
Switzerland 17) were available, and the majority (68%) were 
operated under public ownership. The perception of RAL 
and the anticipated superiority of RAL significantly differed 
between robotic and non-robotic surgeons. For only two 
 urologic indications were more than 50% of the procedures 
performed using RAL: pyeloplasty (58%) and transperitoneal 
radical prostatectomy (75%). On average, 35% of robotic sur-
geons and only 14% of non-robotic surgeons anticipated RAL 
superiority in some of the 25 indications.  Conclusions: This 
survey provides a detailed insight into RAL implementation 
in Germany,  Austria and Switzerland. RAL is currently limited 
to a few urological indications with a small number of high-
volume robotic centres. These results might suggest that a 
saturation of clinics using RS has been achieved but that the 
existing robotic capacities are being utilized ineffectively. 
The possible reasons for this finding are discussed, and cer-
tain strategies to solve these problems are offered. 
 © 2015 S. Karger AG, Basel 
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 Abstract 
 Background: Robotic-assisted laparoscopy (RAL) is being 
widely accepted in the field of urology as a replacement 
for conventional laparoscopy (CL). Nevertheless, the process 
of its integration in clinical routines has been rather sponta-
neous.  Objective: To determine the prevalence of robotic 
 systems (RS) in urological clinics in Germany, Austria and 
 Switzerland, the acceptance of RAL among urologists as a re-
placement for CL and its current use for 25 different urologi-
cal indications.  Materials and Methods: To elucidate the 
practice patterns of RAL, a survey at hospitals in Germany, 
Austria and Switzerland was conducted. All surgically active 
urology departments in Germany (303), Austria (37) and 
 Switzerland (84) received a questionnaire with questions re-
lated to the one-year period prior to the survey.  Results: The 
response rate was 63%. Among the participants, 43% were 
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 Introduction 
 Since the introduction of robot-assisted laparoscopy 
(RAL) into urologic surgery  [1–3] , its indications and ac-
ceptance among surgeons have developed rapidly, sup-
ported by the rising numbers of publications and emerg-
ing evidence of its functional and oncological equiva-
lence to conventional laparoscopy (CL). Contemporary 
reviews and meta-analyses have prompted current 
 European guideline recommendations  [4] justifying ro-
botic surgery for several indications, such as nephrecto-
my, partial nephrectomy, pyeloplasty, radical prostatec-
tomy, pelvic lymph-node dissection, sacrocolpopexy and 
radical cystectomy with urinary diversion. However, 
high-quality mature data on robotics are still lacking, 
with most of the results functionally compromised by the 
surgeons’ learning curves and limited long-term results. 
Nonetheless, recent publications have been able to prove 
equivalent results for RAL compared to CL for several in-
dications, namely partial nephrectomy  [5] , pyeloplasty 
 [6] and radical prostatectomy  [7–9] .
 Other than concerns as to RAL outcomes, the eco-
nomics of operating a robotic system (RS) are currently 
under debate. Several publications from varying health-
care systems have demonstrated the increased costs of 
RAL compared to CL approaches and failed to clearly 
identify any economic advantages of RAL, except for 
RAL partial nephrectomy and pyeloplasty  [10, 11] . Equiv-
alency of expenses could not be proven for either radical 
prostatectomy or cystectomy in the United States; corre-
sponding data from European countries are limited  [12, 
13] or pending  [14] . As background for any future con-
siderations further, comprehensive data on the availabil-
ity of RAL, the number of procedures performed using 
RAL, the accepted indications and the professional atti-
tude towards RAL are required.
 To obtain these data for German-speaking countries 
in Europe, this study was conceived as a collaborative 
project with the working group ‘laparoscopy and robot-
assisted surgery’ of the German urological society, in co-
operation with Austrian, Swiss Urological Associations 
and the European Society of Urologic Technology.
 Materials and Methods 
 Study Design and Participants 
 A survey was conducted to assess the use of laparoscopy (pub-
lished recently in  [15] ) and RAL in Germany, Austria and 
 Switzerland. A questionnaire (online suppl. Appendix; for all on-
line suppl. material, see www.karger.com/doi/10.1159/000430502) 
was sent to 303 urology departments in Germany, 37 in Austria 
and 84 in Switzerland using the address databases of professional 
societies. Three methods of response were offered: postal mail, fax 
or web-based questionnaire with personal log-in.
 Questionnaire Design 
 The questionnaire issued in German was developed to be anon-
ymous and self-administered and was initially validated by ten ex-
perienced urologists from the authors’ university hospitals. The 
questionnaire was machine-readable and consisted of two parts, 
capturing general data related to the type and size of institution 
and number of operating surgeons (including their age) and then 
assessing the availability of robotic system(s), its implementation 
in clinical routines, attitudes towards RAL among urologists and 
concerns about its efficacy. The questionnaire investigated the 
number of procedures performed by CL and RAL for one year 
prior to the survey at 25 different urological indications. Addition-
ally, the anticipated superiority of RAL at these specific indications 
was assessed.
 Data Analysis 
 All questionnaires were scanned, followed by digital character 
recognition and automated database entries, controlling for the 
quality of data processing. One of the primary aims was to compare 
the data obtained from robotic and non-robotic institutions. 
 Descriptive statistical analysis was carried out using Microsoft ® 
Excel ® (Redmond, USA).
 Results 
 Response Rate 
 The questionnaire was returned by 212 (70%) depart-
ments in Germany, 28 (76%) in Austria, and 29 (35%) in 
Switzerland, for an overall response rate of 63%.
 Availability/Distribution of Robotic Systems for RAL 
and Types of Institutions 
 In 2012, 60 (22.3% of all responding hospitals) robotic 
systems were available at the participating hospitals (35 
in Germany, 8 in Austria and 17 in Switzerland). The ma-
jority of the robot-equipped institutions were either uni-
versity (n = 26; 43%) or tertiary care (n = 27; 45%) clinics, 
with only 8% (n = 5) identifying as secondary care clinics 
and two robotic responders from Germany failing to pro-
vide the information ( fig. 1 ). As for the ownership of the 
participating clinics ( fig. 2 ), the majority (n = 41; 68%) of 
the hospitals were public, with some differences detected 
among the participating countries.
 Size of the Surgical Teams and Age Distribution of the 
Surgeons at Robotic and Non-Robotic Institutions 
 The size of the minimally invasive and conventional 
(open) surgical teams and the age distribution of the 
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 surgeons were analysed. Minimally invasive teams in 
non-robotic institutions consisted of a mean number of 
2.4  surgeons, and conventional teams consisted of 3.6 
surgeons (vs. 3.0 and 4.3 for robot-operating institu-
tions,  correspondingly). The minimally invasive and 
conventional surgical teams contained 1.3- and 1.2-fold 
more members at robotic centres, correspondingly. 
Only  minor differences were observed with regard to 
the age  distribution of the surgeons, with a tendency to-
wards younger minimally invasive surgeons at robotic 
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 departments ( fig. 3 a, b). A few participants (convention-
al surgical teams n = 5, 8.3%; minimally invasive surgical 
teams n = 7, 11.7%) did not provide information about 
their teams.
 Attitude Towards Robot-Assisted Laparoscopy 
 Figure 4 represents the individual attitude of the re-
sponders towards RAL, focusing on its cost-effectiveness, 
marketing aspects and perceived influence on urologic 
surgery. Generally, a substantial proportion of both ro-
botic (75%; surgeons regularly, not sporadically, operat-
ing with the use of robotic system) and non-robotic sur-
geons (98%) considered RAL to be cost-ineffective. Nev-
ertheless, more than 50% of surgeons in each group 
classified RAL as an ‘important marketing tool’. Notably, 
two times more robotic surgeons believe that RAL will 
replace CL (60 vs. 33%). A substantial proportion of ro-
botic surgeons expected better functional and oncological 
results from RAL; on the contrary, these beliefs were rel-
atively faint in the non-robotic group.
 Estimated Superiority of RAL for Different Urologic 
Indications 
 Interestingly, the response rate to this questionnaire 
complex varied significantly among robotic (32–65%) 
and non-robotic surgeons (28–41%). On average, 50% 
of all robotic participants did not indicate a value for 
RAL regarding individual indications when asked to lo-
cate the perceived superiority of RAL. In general, ro-
botic surgeons were more convinced of the advantages 
of RAL than non-robotic surgeons ( fig. 5 ). Importantly, 
among the selected indications, approximately 40% of 
non-robotic surgeons would prefer to operate using an 
RS.
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 Proportion of RAL Procedures for Urological 
Indications at Robotic Institutions 
 All robot-equipped institutions were asked to specify 
the number of procedures (year prior to survey) for 25 
indications and the proportion of robot-assisted proce-
dures for each ( fig. 6 ). The average response rate was 89% 
(range 87–98%).
 The proportion of robotic operations for the selected 
indications varied significantly (the average use was 21%; 
range 0–75%). For 8 of the 25 indications ( fig. 6 ), the pro-
portion of RAL surgeries exceeded 30%; for two indica-
tions (transperitoneal prostatectomy and pyeloplasty), 
the value exceeded 50%. Intensive implementation of 
RAL procedures was limited to a few centres and few uro-
logic indications.
 Discussion 
 The presented survey is the first published report on 
the current patterns of use of urological RAL in German-
speaking countries. In contrast to previous articles, which 
have focused on the description or refinements of robot-
ic techniques  [16, 17] , robotic standards and equiva-
lence or superiority  [6–8, 18, 19] , we provide comprehen-
sive data on the availability of RS, their distribution and 
the use of RAL in urologic surgical routines. Recently 
published articles have dealt predominately with the eco-
nomic aspects of RAL under different healthcare systems, 
indicating any increased direct costs associated with RAL 
 [11–13, 20] . The current survey evaluates the attitudes 
and patterns of use for RAL. The economics of the ro-
botic system were not within the focus of our study.
 This survey had a moderate overall response rate of 
63%, with response rates in Germany and Austria above 
70% and indicating a sufficient representation of the 
 clinics. Nonetheless, the results gathered for Switzerland 
are limited by a low response rate of 35% (29 out of 84 
recipients) and an above-average proportion of robotic 
institutions (59%). It remains unclear, why, in compari-
son to Austria and Germany, Swiss robotic surgeons were 
attracted to participate in this survey. According to the 
information provided by Intuitive Surgical ® (Sunnyvale, 
CA 94086–5304, USA), almost all (60/63 systems, 95.2%) 
robotic centres were responders.
 Overall, 60 clinics operated RS. Interestingly, given the 
10-fold population of Germany compared to Switzerland, 
only twice as many more robotic systems are being used 
in Germany. Although this could be influenced by the 
wealth and financial aspects of each country, this discrep-
ancy raises some important questions. How many uro-
logic robotic systems are needed per population size per 
clinically accepted surgical indication? This could be a 
first step to the optimal and rational saturation of clinics 
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with RS. One could argue that this is not possible before 
clear advantages of robotic surgery are proven. Neverthe-
less, robotic surgical systems are already present.
 The survey demonstrated that robotic systems are, as 
generally anticipated, used at the surgical centres of high 
care levels, which contain the majority of urologic depart-
ments (84% university and tertiary care vs. 16% second-
ary care hospitals), not counting the 8% being operated at 
secondary care institutions ( fig. 1 ). This is an important 
issue to consider and warrants further investigation to 
determine whether these latter clinics have developed or 
use an effective economic model for the maintenance.
 The ongoing discussion of RAL-associated costs and 
their insufficient reimbursement in different healthcare 
system models  [11–13, 20] raises the question as to which 
hospitals can adequately bear these expenditures to ben-
efit from the potential advantages of RAL (e.g. market-
ing). Our study shows that mostly public authorities agree 
to address the potential financial or entrepreneurial risks 
of operating a robotic system, whereas private companies 
in Germany mostly seem to avoid these risks, possibly due 
to the diagnosis-related groups (DRG) system-related 
under-financing of robotic cases.
 The implementation of robotic systems in urology is 
hampered by the restrictive nature of reimbursement reg-
ulation. Only a minority of urologists from both robotic 
and non-robotic institutions believe that RAL is operated 
cost-effectively. Nevertheless, our survey shows that at 
least some clinics have been able to develop effective fi-
nancial models to maintain the high workload of the ro-
botic systems. Still, only a minority of these institutions 
plan to introduce a new RS into their armamentarium. 
This finding is understandable among those institutions 
already using an RS. However, the faint positive reaction 
from non-robotic institutions allows us to assume that 
the ‘climax’ of robotic dissemination has passed. There 
does remain a prominent agreement within the urologi-
cal society that such robots are a powerful marketing tool 
for any institution.
 Almost two-thirds of all RAL surgeons believe that ro-
bots will replace CL in the future. This dominating opin-
ion represents the driving force behind the development 
of RAL and its enforced introduction into the urological 
surgery. This opinion is mostly based on the demonstrat-
ed advantages a robotic system gives to an operating sur-
geon, even when such benefits are subjective and not re-
lated to the outcomes.
 Robotic surgeons voiced a prominent conviction that 
RAL provides both better functional and oncological re-
sults compared to CL, although current guidelines  [4] 
and recent publications  [4–9, 13, 14, 18, 21, 22] were able 
to show only equivalency. Studies providing answers to 
these questions with higher evidence levels are pending 
 [14] .
 As for the age distribution within robotic and non-
robotic surgical teams, it could be stated that robotic in-
stitutions might offer earlier minimally invasive training 
compared to non-robotic institutions ( fig. 3 a, b). To date, 
education related to the robotics is still an open question. 
The survey demonstrated, that both open (3.6 vs. 4.3) and 
minimally invasive (2.4 vs. 3.0) surgical teams at robotic 
centres consisted of more team members. It remains un-
clear, if the operation of robot systems requires more 
staff, if higher care levels of robotic centres cause these 
team sizes, if robotic centres are more successful in per-
sonal recruitment or if robotic clinics can afford intensi-
fied surgical education.
 One of the important parts of this survey was its evalu-
ation of the anticipated superiority of RAL for 25 different 
urologic surgical indications. Interestingly, the response 
rate to these questions was relatively low, compared to 
other issues, ranging from 32–65% among robotic and 
from 28–41% among non-robotic institutions ( fig. 5 ). It 
is obvious that the values given by the robotic surgeons 
could be significantly biased by their general adherence 
to robotic technology; the answers from the non-robotic 
clinics may have been more objective. Many robotic sur-
geons tend to expect better functional and oncological 
results. This can hardly be explained only by their attach-
ment to a ‘favourite toy’. Thus, for several indications, the 
perceived superiority of RAL reached 30%, indicating the 
necessity of deeper evaluations of the reasons behind 
these opinions held by professionals. Not surprisingly, for 
some indications, the RAL superiority acceptance reached 
and surpassed the 50% mark. Cystectomy with intracor-
poral urinary diversion, transperitoneal radical prosta-
tectomy and pyeloplasty certainly constitute important 
urological procedures entailing a vast amount of required 
suturing. No preference of surgical approach in kidney 
oncology was noted.
 The rising number of publications on robot-assisted 
laparoscopy in urology suggests that this approach plays 
a crucial role in minimally invasive surgery. However, to 
date, no reports on the use of RAL in urology are avail-
able. This study provides comprehensive insight into the 
patterns of use for urological RAL in three countries 
( fig.  6 ). The proportion of robotic procedures varies 
widely among urologic indications and centres. Only py-
eloplasties and transperitoneal radical prostatectomies 
are performed in more than half of cases using RAL at 
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participating robotic centres. Moreover, the survey im-
pressively demonstrated that RAL is being performed on 
a considerable number of patients for only a few indica-
tions at a few robotic centres. These findings raise several 
questions:
 • How much and why is RAL limited by its added costs? 
 • Given the insufficient degree of utilization of the 60 
available systems, are they being used predominately 
for marketing reasons? 
 • How can a few robotic centres successfully perform 
high frequencies of RAL without economic draw-
backs? 
 These issues warrant further consideration in addi-
tional studies.
 Future Directions 
 Our study leads us to think that the saturation of the 
medical systems in Germany, Switzerland and Austria 
with robotic systems under contemporary conditions is 
probably at its peak. Therefore, the question that arises 
now is not whether urology should embrace robotic sur-
gery, but how best can we use it. It is more or less clear that 
robotic surgery has strong applications in several proce-
dures and that its expansion will continue. Another impor-
tant question is whether the urological community would 
choose robotics in the face of the similar functional and 
oncological outcomes. The answer is probably yes because 
robotic surgeons express a strong attachment to this type 
of surgery. Neglecting the learning curve of robotic sur-
gery, the main restrictions presumably are the associated 
costs. Once these problems are overcome, robotics will 
penetrate the clinical routine. Therefore, certain important 
steps must be made to solve financial difficulties. First, the 
economics of robotic surgery should be analysed in the ro-
botic institutions. As a result of this analysis, one or sev-
eral effective financial models should be developed for fur-
ther generalization in other robotic centres. Second, the 
reimbursement system should be optimized with regards 
to robotic surgery. Third and most important, competitive 
robotic systems are urgently needed because this is one of 
the main ways to reduce costs. Fourth, adequate regulation 
of the indications for robotic surgery is needed.
 Some limitations should be outlined for our survey. 
One of the main limitations is the 63% response rate. This 
could lead to a distorted reflection of the current patterns 
of use for CL and RAL. Moreover, the information pro-
vided was in part subjective; therefore, individual-related 
issues could affect the quality of our data.
 Drawing a conclusion, the present survey of urologic 
surgeons in Germany, Austria and Switzerland is the 
first report on previously unpublished aspects of robot-
assisted laparoscopy. The main finding is a relatively 
pronounced saturation of clinics with robotic systems, 
which seem to be utilized ineffectively, probably due to 
the absence of adequate financial regulation. In fact, 
only a minority of robotic surgeons believe in the cost-
effectiveness of RAL. The survey clearly demonstrates 
that RAL is currently limited to certain important uro-
logical indications and that only a small number of 
high-volume centres have an acceptable workload. The 
possible reasons behind these findings are discussed, 
and certain strategies to solve these problems are speci-
fied.
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